Streetbeat News

Products Services

TSLA

SAE International, a global association of engineers and technical experts, is aiming to standardize Tesla's charging standard within six months or less, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 5:56 pm

RCEL

Cantor Fitzgerald has initiated coverage on Avita Medical Inc (NASDAQ:RCEL) with an Overweight rating and a price target of $23. The analyst believes that Avita's RECELL system will disrupt traditional skin grafts, requiring significantly less donor skin. The system also reduces the number of autograft procedures and hospital stay length. The company can tap into an additional 10,000 annual burn procedures and approximately 110,000 acute wound procedures, suggesting a total addressable market (TAM) of $1.0 billion. Furthermore, an estimated 1.3 million stable vitiligo procedures in the U.S. indicate a potential TAM of $5.2 billion.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:51 pm

ARGX

UCBJF

UCBJY

The FDA has approved UCB SA's Rystiggo for generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positive. Rystiggo is the only FDA-approved treatment for these two most common subtypes of gMG. The approval is based on data from the Phase 3 MycarinG study. Rystiggo will be commercially available in the U.S. in Q3 2023. Last week, the FDA also approved Argenx SE's Vyvgart Hytrulo for gMG in adult patients who are anti-acetylcholine receptor antibody positive.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:47 pm

MGTX

MeiraGTx Holdings plc (NASDAQ:MGTX) has released data from its completed Phase 1 AQUAx study of AAV2-hAQP1 for grade 2/3 radiation-induced xerostomia (RIX). The study showed clinically meaningful improvements in xerostomia symptoms and increases in whole saliva flow rates post-treatment. The company has initiated a Phase 2 randomized, double-blind, placebo-controlled study. MGTX shares are down 4.53% at $6.53 on the last check Tuesday.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:41 pm

PARA

ROKU

Roku Inc (NASDAQ:ROKU) has announced its first live sports rights package, becoming the official streaming home of motorsports league Formula E in the U.S. The Roku Channel will offer on-demand replays, race previews, highlights, and past docuseries starting from the 2024 season. CBS Sports, a unit of Paramount Global (NASDAQ:PARA)(NASDAQ:PARAA), has also expanded its deal with the league. The move comes as media companies compete for sports content rights as consumers shift to streaming services.

Portfolio Pulse from Chris Katje

June 27, 2023 | 5:41 pm

NVDA

SNOW

TSLA

TSM

Nvidia Corp (NVDA) is benefiting from the artificial intelligence boom, with Snowflake Inc (SNOW) using Nvidia's technology for AI applications and a strong demand for Nvidia GPUs in China. However, Tesla Inc (TSLA) is planning to reduce its reliance on Nvidia by developing its own AI chips. Despite the positive outlook, a finance professor at NYU values Nvidia's shares at $240, well below the current price of $415.08.

Portfolio Pulse from Anusuya Lahiri

June 27, 2023 | 5:26 pm

NKTX

Nkarta Inc (NASDAQ:NKTX) announced updated data from the Phase 1 study of NKX101 for treating acute myeloid leukemia (AML). The results showed a 67% complete response rate in one cohort and a 22% complete response rate in another. However, the company's shares fell by 34.20% following the announcement.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:23 pm

LLY

NRBO

NVO

NeuroBo Pharmaceuticals' weight loss candidate, DA-1726, has shown superior weight loss efficacy in preclinical testing compared to Semaglutide and Tirzepatide, products of Novo Nordisk and Eli Lilly respectively. DA-1726 also demonstrated superior efficacy compared to cotadutide in reducing body weight and improving plasma glucose, insulin, and HOMA-IR in diet-induced obese mice. NeuroBo plans to initiate a phase 1a safety study for DA-1726 in 1H of 2024.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:20 pm

ACET

Adicet Bio has released safety and efficacy data from its Phase 1 ADI-001 study for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma, which has led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 5:16 pm

RGF

WMT

Real Good Food Company Inc (NASDAQ:RGF) is expanding its Breaded Chicken and Asian Entrees platforms into Walmart Inc. (NYSE:WMT) stores nationwide. By the end of June 2023, over 4,000 Walmart stores will carry these items. This expansion is expected to reach over 90% of all Americans as they live within ten miles of a Walmart store. However, RGF shares are trading lower by 3.39% at $3.42.

Portfolio Pulse from Shivani Kumaresan

June 27, 2023 | 5:16 pm